AI Article Synopsis

  • The study investigates the prevalence of autonomic dysfunction in wild-type transthyretin amyloidosis (ATTR) using a noninvasive method called R-R interval coefficient of variation (CVR-R).
  • A retrospective analysis was conducted on 50 heart failure patients, comparing CVR-R among different causes of heart failure, including ATTR, myocardial infarction, and left ventricular hypertrophy.
  • The results showed significantly lower CVR-R levels in the ATTR group, indicating autonomic dysfunction, and identified a CVR-R cutoff value of 19.7 that may help in detecting ATTR in heart failure patients.

Article Abstract

Background And Aims: An autonomic nervous disorder is an important characteristic of cardiac amyloidosis; however, the prevalence of autonomic dysfunction in wild-type transthyretin amyloidosis (ATTR) has not been established. Analysis of the R-R interval coefficient of variation (CVR-R) is a noninvasive method to measure parasympathetic activity. We aimed to assess autonomic dysfunction of ATTR and determine the utility of CVR-R for the detection of ATTR in other cardiac diseases.

Methods: This is a single-center, retrospective, case-control study. Fifty patients with heart failure (HF) were studied. The etiologies of HF were as follows: ATTR,  = 10; previous myocardial infarction (MI),  = 20; and left ventricular hypertrophy (LVH) due to other disease processes (e.g., aortic stenosis),  = 20. We measured the CVR-R at rest (CVR-R), CVR-R with deep breaths (CVR-R), and the change rate (CVR-R. The relative change formula is as follows: CVR-R = (CVR-R - CVR-R)/CVR-R  100 (%).

Results: There was no difference in the CVR-R levels among the three groups. The CVR-R levels in the ATTR group were significantly lower (ATTR: -8.77 [-43.8 to 10.9]; LVH: 67.4 [38.7 to 89.4]; MI: 83.7 [60.4 to 142.9]). Based on the receiver operative characteristic curve analysis to identify ATTR in HF, the best cut-off value for the CVR-R was 19.7 (area under the curve: 0.848).

Conclusion: Our data suggested autonomic dysfunction in patients with ATTR. Measurement of the CVR-R in HF patients may be a convenient support tool for the detection of ATTR.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710487PMC
http://dx.doi.org/10.1002/hsr2.938DOI Listing

Publication Analysis

Top Keywords

autonomic dysfunction
12
cvr-r
11
attr
9
r-r interval
8
wild-type transthyretin
8
case-control study
8
detection attr
8
cvr-r levels
8
coefficient r-r
4
interval variations
4

Similar Publications

Patients with chronic kidney disease have a high incidence of cardiovascular diseases, and autonomic dysfunction has a determinant role in the relevant declines. Physical exercise influences heart rate variability and cardiac autonomic modulation. Thus, our objective was to systematically review, with a meta-analysis, the correlation between physical exercise interventions and alterations in cardiac autonomic modulation in hemodialysis patients.

View Article and Find Full Text PDF

Heart rate variability parameters indicate altered autonomic tone in subjects with COVID-19.

Sci Rep

December 2024

Krannert Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

COVID-19 is associated with long-term cardiovascular complications. Heart Rate Variability (HRV), a measure of sympathetic (SNS) and parasympathetic (PNS) control, has been shown to predict COVID-19 outcomes and correlate with disease progression but a comprehensive analysis that includes demographic influences has been lacking. The objective of this study was to determine the balance between SNS, PNS and heart rhythm regulation in hospitalized COVID-19 patients and compare it with similar measurements in healthy volunteers and individuals with cardiovascular diseases (CVD), while also investigating the effects of age, Body Mass Index (BMI), gender and race.

View Article and Find Full Text PDF

Clinical Correlates of Efficacy of Pyridostigmine in the Treatment of Orthostatic Hypotension.

Hypertension

December 2024

Vanderbilt Autonomic Dysfunction Center, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN. (L.E.O., A.D., C.A.S., A.G., B.K.B., S.P., I.B.).

Background: The cholinesterase inhibitor pyridostigmine is used to treat orthostatic hypotension by facilitating cholinergic neurotransmission in autonomic ganglia, thereby harnessing residual sympathetic tone to increase blood pressure (BP) preferentially in the upright posture. We hypothesized that less severe autonomic impairment was associated with greater pressor responses to pyridostigmine.

Methods: To identify predictors of pressor response, linear regression analyses between the effect of pyridostigmine on upright BP and markers of autonomic impairment were retrospectively conducted on 38 patients who had a medication trial with pyridostigmine (60 mg single dose).

View Article and Find Full Text PDF

Background: Parkinson's disease (PD) and multiple system atrophy (MSA) are classified as α-synucleinopathies and are primarily differentiated by their clinical phenotypes. Delineating these diseases based on their specific α-synuclein (α-Syn) proteoform pathologies is crucial for accurate antemortem biomarker diagnosis. Newly identified α-Syn pathologies in PD raise questions about whether MSA exhibits a similar diversity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!